tiprankstipranks
Trending News
More News >
Extendicare (TSE:EXE)
TSX:EXE
Canadian Market
Advertisement

Extendicare (EXE) Technical Analysis

Compare
210 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Extendicare’s (EXE) Moving Averages Convergence Divergence (MACD) indicator is 0.29, suggesting Extendicare is a Sell.
Extendicare’s (EXE) 20-Day exponential moving average is 13.54, while Extendicare’s (EXE) share price is C$14.25, making it a Buy.
Extendicare’s (EXE) 50-Day exponential moving average is 13.33, while Extendicare’s (EXE) share price is C$14.25, making it a Buy.

Extendicare (EXE) Pivot Points

Sep 27, 2025, 10:44 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.90
14.02
14.14
14.26
14.38
14.50
14.62
Fibonacci
14.02
14.12
14.17
14.26
14.36
14.41
14.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Extendicare (EXE) Moving Averages

Sep 27, 2025, 10:44 AM
Period
Simple
Exponential
MA5
14.09Buy
14.11Buy
MA10
13.69Buy
13.82Buy
MA20
13.37Buy
13.54Buy
MA50
13.08Buy
13.33Buy
MA100
13.52Buy
13.14Buy
MA200
12.50Buy
12.18Buy
Extendicare’s (EXE) 10-Day exponential moving average is 13.82, while Extendicare’s (EXE) share price is C$14.25, making it a Buy.
Extendicare’s (EXE) 100-Day exponential moving average is 13.14, while Extendicare’s (EXE) share price is C$14.25, making it a Buy.
Extendicare’s (EXE) stock price is C$14.25 and Extendicare’s (EXE) 50-day simple moving average is 13.08, creating a Buy signal.
Extendicare’s (EXE) stock price is C$14.25 and Extendicare’s (EXE) 100-day simple moving average is 13.52, creating a Buy signal.
Extendicare’s (EXE) stock price is C$14.25 and Extendicare’s (EXE) 200-day simple moving average is 12.50, creating a Buy signal.

Extendicare (EXE) Technical Indicators

Sep 27, 2025, 10:44 AM
Name
Value
Implied Action
RSI (14)
73.88
Sell
STOCH (9,6)
93.96
Sell
STOCHRSI (14)
94.41
Sell
MACD (12,26)
0.29
Sell
ADX (14)
19.23
Buy
Williams %R
-1.26
Sell
CCI (14)
195.45
Sell
ATR (14)
0.30
-
Ultimate Oscillator
68.01
Neutral
ROC
9.92
Buy
Extendicare’s (EXE) Relative Strength Index (RSI) is 73.88, creating a Sell signal.
Extendicare’s (EXE) Trend Strength Indicator (ADX) is 19.23, creating a Buy signal.
Extendicare’s (EXE) Commodity Channel Index (CCI) is 195.45, creating a Sell signal.
Extendicare’s (EXE) Price Rate of Change (ROC) is 9.92, creating a Buy signal.

FAQ

Is EXE a Buy, Hold, or Sell?
Based on EXE’s technical indicators, EXE is a Buy.
    What is EXE’s RSI (14)?
    EXE’s RSI (14) is 73.88, which suggests EXE is a Sell.
      What is EXE’s MACD?
      EXE’s MACD is 0.29, which suggests EXE is a Sell.
        What is EXE’s 5-day moving average?
        EXE’s 5-day moving average is 14.09, which suggests EXE is a Buy.
          What is EXE’s 20-day moving average?
          EXE 20-day moving average is 13.37, which suggests EXE is a Buy.
            What is EXE’s 50-day moving average?
            EXE’s 50-day moving average is 13.08, which suggests EXE is a Buy.
              What is EXE’s 200-day moving average?
              EXE’s 200-day moving average is 12.50, which suggests EXE is a Buy.
                What is EXE’s Williams % R (14)?
                EXE’s Williams % R (14) is -1.26, which suggests EXE is a Sell.
                  What is EXE’s CCI (14)?
                  EXE’s CCI (14) is 195.45, which suggests EXE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis